LT
LTZ Therapeutics
United States · Biotech · Healthtech · AI
LTZ Therapeutics develops cancer immunotherapies that target myeloid biology.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Undisclosed | $38M | GL Ventures — Role not disclosed |